Preclinical validation of AR42, a novel histone deacetylase inhibitor, as treatment for vestibular schwannomas

Abraham Jacob, Janet Oblinger, Matthew L. Bush, Victoria Brendel, Griffin Santarelli, Abhik R. Chaudhury, Samuel Kulp, Krista M.D. La Perle, Ching Shih Chen, Long Sheng Chang, D. Bradley Welling

Research output: Contribution to journalArticlepeer-review

32 Scopus citations

Fingerprint

Dive into the research topics of 'Preclinical validation of AR42, a novel histone deacetylase inhibitor, as treatment for vestibular schwannomas'. Together they form a unique fingerprint.

Medicine & Life Sciences